EFFICACY AND SAFETY OF UPADACITINIB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: FINAL RESULTS FROM THE PHASE 3 U-ACHIEVE MAINTENANCE STUDY

Severine Vermeire  ¹     Silvio Danese  ²     Wen Zhou  ³     Xuan Yao  ³     Dapo Ilo  ³     G Levy  ³     Xavier Hebuterne  ⁴     James O. Lindsay  ⁵     Yuri Sanchez Gonzalez     Peter D.R. Higgins     Jean-Frédéric Colombel     Remo Panaccione    
¹ University Hospital Leuven, Leuven, Belgium
² IRCCS, Milan, Italy
³ AbbVie Inc., North Chicago, United States
⁴ CHU de Nice, Université Côte d’Azur, Nice, France
⁵ The Royal London Hospital, Barts Health NHS T

Session
Opening Session Part I

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)